Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin-induced experimental diabetes in rats

Journal of Applied Biomedicine

Volumn 6, Issue 2, 2008, Pages 105-115

  Senthilkumar, Gandhipuram Periasamy ^a   Subramanian, Sorimuthu Pillai ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

C peptide; Diabetes mellitus; Glycoproteins; Streptozotocin; Terminalia chebula

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; CREATININE; FUCOSE; GLIBENCLAMIDE; GLUCOSE; GLYCOPROTEIN; GLYCOSYLATED HEMOGLOBIN; HEXOSAMINE; HEXOSE; INSULIN; SIALIC ACID; TERMINALIA CHEBULA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL RAT; FRUIT; GLUCOSE BLOOD LEVEL; HISTOLOGY; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PANCREAS; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION; UREA BLOOD LEVEL;

RATTUS; TERMINALIA CHEBULA;

EID: 45849088856     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2008.014     Document Type: Article

References (41)

1. Ahn MJ, Kim CY, Lee JS, Kim TG, Kim SH, Lee CK, Lee BB, Shin GG, Huh H, Kim J: Inhibition of HIV-I integrase by galloyl glucose from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med. 68:457-459, 2002.
2. Ananthan R, Baskar C, NarmathaBai V, Pari L, Latha M, Ramkumar KM: Antidiabetic effect of Gymnema montanum leaves: effect on lipid peroxidation induced oxidative stress in experimental diabetes. Pharmacol. Res. 48:551-556, 2003.
3. Asayama K, Nakane T, Uchida N, Hayashibe H, Dobashi K, Nakazawa S: Serum antioxidant status in streptozotocin-induced diabetic rat. Horm. Metab. Res. 26:313-315, 1994.
4. Brod J, Sirota JH: The renal clearance of endogenous is creatinine in man. J. Clin. Invest. 27:645-654 1948.
5. Bucala R: Advanced glycosylation end products and diabetic vascular diseases. In Keaney J.F. Jr. (ed.): Oxidative Stress and Vascular Disease, Kluwer Acad. Publishers, Dordrecht 1999, pp. 287-303.
6. Cerami A, Koenig RJ, Peterson CM, Stevens VJ: The formation of Hb Alc as a biochemical model for the sequelae of diabetes. Prog. Clin. Biol. Res. 21:33 45, 1978.
7. Chatterjee S, Pakrasi SC: The Treatise on Indian Medicinal Plants, Vol. 3, National Institute of Science Communication and Information Resource, 2000, pp. 203-204.
8. Dighe RR, Rojas FJ, Birnbaumer L, Garber AJ: Glucagon stimulates adenylate cyclase in rat liver. The impact of STZ-induced diabetes mellitus. J. Clin. Invest. 73:1013-1023, 1984.
9. Dische Z, Shettles LB: A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J. Biol. Chem. 175:595-603, 1948.
10. Gavella M, Lipovac V, Car A, Vucic M, Sokolic L, Rakos R: Serum sialic acid in subjects with impaired, glucose tolerance and in newly diagnosed type 2 diabetic patients. Acta Diabetol. 40:95-100, 2003.
11. Gordon K, Bradbury P: Microtomy and paraffin sections. In Bancroft JD, Stevens A. (eds.): Theory and Practice of Histological Techniques, Churchill Livingston, New York 1990, pp. 61-80.
12. Grunberger G, Sima AA: The C-peptide signaling. Exp. Diabesity Res. 5:25-36, 2004.
13. Gupta BL, Nehal M, Baquer NZ: Effect of experimental diabetes on the activities of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages. Indian J. Exp. Biol. 35:792-795, 1997.
14. Juang LJ, Sheu SJ, Lin TC: Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J. Sep. Sci. 27:718-724, 2004.
15. Kaur S, Arora S, Kaur K, Kumar S: The in vitro antimutagenic activity of Triphala - an Indian herbal drug. Food Chem. Toxicol. 40:527-534, 2002.
16. Knecht KT, Bradford BU, Mason RP, Thurman RG: In vivo formation of a free radicals metabolite of ethanol. Mol. Pharmacol. 38:26-30, 1990.
17. Konukoglu D, Serin O, Akcay T, Hatemi H: Relationship between diabetic angiopathic complications and serum total and lipid associated sialic acid concentrations. Med. Sci. Res. 27:53-55, 1999.
18. Li WL, Zheng HC, Bukuru J, De Kimpe N: Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 92:1-21, 2004.
19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275, 1951.
20. Mittal N, Karur J, Mahmood A: Changes in tubular membrane glycosylation in diabetic, insulin and thyroxin treated rat kidneys. Indian J. Exp. Biol. 34:782-785, 1996.
21. Mondoa EI, Kitei M: The new healing science of glyconutrients. In: Sugars that Heal, Ballantine Publishing, New York, 2001.
22. Moussa MA, Alsaeid M, Refai TM, Abdella N, Al-Sheikh N, Gomez JE: Association of serum sialic acid with cardiovascular metabolic risk factors in Kuwaiti children and adolescents with type 1 diabetes. Metabolism 53:638-643, 2004.
23. Natelson S, Scott ML, Beffa C: A rapid method for the estimation of urea in biologic fluids. Am. J. Clin. Pathol. 21:275-281, 1951.
24. Nayak SS, Pattabiraman TN: A new colorimetric method for the estimation of glycosylated hemoglobin. Clin. Chim. Acta 109:267-274, 1981.
25. Niebes P: Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin. Chim. Acta 42:399-408, 1972.
26. Patti ME, Virkamaki A, Landaker EJ, Kahan CR, Yki-Jarvinen H: Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48: 1562-1571, 1999.
27. Rahman MA, Zafar G, Shera AS: Changes in glycosylated proteins in long-term complications of diabetes mellitus. Biomed. Pharmacother. 44:229-234, 1990.
28. Rakieten N, Rakieten ML, Nadkarni MV: Studies on the diabetogenic action of streptozotocin. Cancer Chemother. Rep. 29:91-98, 1963.
29. Ramkumar KM, Rajagura P, Latha M, Ananthan R: Ethanol extract of Gymnema montanum leaves reduces glycoprotein components in experimental diabetes. Nutr. Res. 27:97-103, 2007.
30. Rannels DE, Mokee DE, Morgan HE: Biochemical action of hormones. In Lit Wag G (ed.): Biochemical Action of Hormones. Acad. Press, New York 1997, pp. 135-195.
31. Sabu MC, Kuttan R: Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J. Ethanopharmacol. 81:155-160, 2002.
32. Saleem A, Husheem M, Harkonen P, Pihalaja K: Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J. Ethnopharmacol. 81:327-336, 2002.
33. Sasaki T, Matsy S, Sonae A: Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku 1:346-353, 1972.
34. Senthilkumar GP, Arulselvan P, Sathishkumar D, Subramanian SP: Anti-Diabetic activity of fruits on Terminalia chehula on Streptozotocin induced diabetic rats. J. Health Sci. 52:281-289, 2006.
35. Sharma C, Dalferes FR, Radhakrishnamurthy B, De-Paolo CJ, Berenson GS: Hepatic glycoprotein synthesis in streptozotocin diabetic rats. Biochem. Int. 15-19, 1987.
36. Sharma RK, Dash B Carka Sambita: Volume II.: Chowkamba Sanskrit Series Office, Varanasi, India 1998.
37. Spiro RG, Spiro MJ: Effect of diabetes on the biosynthesis of the renal glomerular basement membrane: Studies on the glucosyltransterase Diabetes 20:641-648, 1971.
38. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T: Functional consequences of Streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol. Rev. 44:103-150, 1992.
39. Wagner WD: A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal. Biochem. 94:394-396, 1979.
40. Warren L: The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975, 1959.
41. Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID: Skeletal musle content of membrane glycoproteins PC-1 in obesity. Relationship of muscle glucose transport. Diabetes 45:585-587, 1996.